Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Corcept Therapeutics (NQ: CORT ) 43.93 +0.65 (+1.50%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Corcept Therapeutics < Previous 1 2 3 4 5 Next > Forecasting The Future: 6 Analyst Projections For Corcept Therapeutics September 18, 2024 Via Benzinga NASDAQ:CORT is not too expensive for the growth it is showing. September 17, 2024 Investors should take note ofCORCEPT THERAPEUTICS INC (NASDAQ:CORT), a growth stock that remains attractively priced. Via Chartmill NASDAQ:CORT: a strong growth stock preparing for the next leg up?. September 09, 2024 Exploring the Growth Potential of CORCEPT THERAPEUTICS INC (NASDAQ:CORT) as It Nears a Breakout. Via Chartmill For those who appreciate growth without the sticker shock, NASDAQ:CORT is worth considering. August 27, 2024 Don't overlook CORCEPT THERAPEUTICS INC (NASDAQ:CORT)—a stock with solid growth prospects and a reasonable valuation. Via Chartmill NASDAQ:CORT: a strong growth stock preparing for the next leg up?. August 16, 2024 CORCEPT THERAPEUTICS INC (NASDAQ:CORT)—Positioned as a High-Growth Stock, Ready for a Potential Breakout. Via Chartmill NASDAQ:CORT is not too expensive for the growth it is showing. August 05, 2024 Don't overlook NASDAQ:CORT—a stock with solid growth prospects and a reasonable valuation. Via Chartmill Unveiling 8 Analyst Insights On Corcept Therapeutics July 30, 2024 Via Benzinga 6 Analysts Have This To Say About Corcept Therapeutics June 17, 2024 Via Benzinga NASDAQ:CORT is not too expensive for the growth it is showing. May 31, 2024 NASDAQ:CORT is showing good growth, while it is not too expensive. Via Chartmill Corcept Therapeutics Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) May 29, 2024 Via Benzinga CORT Stock Earnings: Corcept Therapeutics Beats EPS, Beats Revenue for Q2 2024 July 29, 2024 CORT stock results show that Corcept Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Why NASDAQ:CORT Is a Promising High-Growth Stock in the Midst of Consolidation. July 15, 2024 CORCEPT THERAPEUTICS INC (NASDAQ:CORT) qualifies as a high growth stock and is consolidating. Via Chartmill Investors seeking growth at a reasonable cost should explore NASDAQ:CORT. July 15, 2024 For those who appreciate growth without the sticker shock, CORCEPT THERAPEUTICS INC (NASDAQ:CORT) is worth considering. Via Chartmill 7 Biotech Stocks to Boost Your Portfolio to Peak Health June 26, 2024 With biotech stocks commanding a permanently relevant narrative, you can’t afford to ignore these highly endorsed ideas. Via InvestorPlace Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for June 2024 June 26, 2024 Selecting strong buy biotech stocks isn’t easy when most of them don’t make money. Here are three possibilities to meet this challenge. Via InvestorPlace While growth is established for NASDAQ:CORT, the stock's valuation remains reasonable. June 24, 2024 CORCEPT THERAPEUTICS INC (NASDAQ:CORT) is showing good growth, while it is not too expensive. Via Chartmill Exploring the Growth Potential of NASDAQ:CORT as It Nears a Breakout. May 09, 2024 Exploring the Growth Potential of CORCEPT THERAPEUTICS INC (NASDAQ:CORT) as It Nears a Breakout. Via Chartmill The Analyst Verdict: Corcept Therapeutics In The Eyes Of 4 Experts May 02, 2024 Via Benzinga Concerpt Therapeutics Shares Are Trading Lower: What You Need To Know June 14, 2024 Corcept Therapeutics Inc. (NASDAQ: CORT) shares are trading lower Friday afternoon following a report suggesting Teva Pharmaceuticals Inc. (NYSE: TEVA) has sued the company, accusing it of a monopoly... Via Benzinga Topics Lawsuit Exposures Financial Legal Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session June 14, 2024 Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session June 03, 2024 Via Benzinga Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 28, 2024 Via Benzinga Nvidia, Insmed, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday May 28, 2024 Via Benzinga Why Mid-Cap Corcept Therapeutics Stock Trading Higher On Tuesday? May 28, 2024 Corcept Therapeutics announced the GRACE Phase 3 trial results for relacorilant in Cushing's syndrome, showing significant improvements in hypertension and hyperglycemia. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 28, 2024 Via Benzinga While growth is established for NASDAQ:CORT, the stock's valuation remains reasonable. May 10, 2024 Don't overlook CORCEPT THERAPEUTICS INC (NASDAQ:CORT)—a stock with solid growth prospects and a reasonable valuation. Via Chartmill 10 Health Care Stocks With Whale Alerts In Today's Session May 09, 2024 Via Benzinga CORT Stock Earnings: Corcept Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 01, 2024 CORT stock results show that Corcept Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Mid-Cap Corcept Therapeutics Reveals Data From Hormonal Disorder Study, FDA Application Submission Expected This Quarter April 22, 2024 Insights from Corcept Therapeutics' Phase 3 GRACE trial results for endogenous Cushing's syndrome. Discover rapid improvements in hypertension and hyperglycemia without adverse effects. Join us for the... Via Benzinga Exposures Product Safety While growth is established for NASDAQ:CORT, the stock's valuation remains reasonable. April 19, 2024 For those who appreciate growth without the sticker shock, CORCEPT THERAPEUTICS INC (NASDAQ:CORT) is worth considering. Via Chartmill < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.